Abstract
We thank Dr. Bruzzone for her interest in our article.1 We agree that participation in the study per se could have impacted outcomes. In particular, as pointed out in our Discussion, patients in the control group were also administered the questionnaire, and therefore, they might have been sensitized to report adverse effects that otherwise could have been neglected. We also agree that screening for adverse effects should be part of the routine management of people with epilepsy. Ideally, this should be supplemented by other measures aimed at raising awareness about the impact of adverse effects on quality of life, and about the strategies that can be applied to optimize drug treatment according to individual needs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
